DURACLON how supplied storage and handling: Difference between revisions
(Created page with "__NOTOC__ {{Clonidine}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click here'''''. ==Indications and Usage== {{Cite web | la...") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 6: | Line 6: | ||
==Indications and Usage== | ==Indications and Usage== | ||
NDC 67457-218-10, 100 mcg/mL solution in | |||
10 mL vials, packaged individually. | |||
NDC 67457-219-10, 500 mcg/mL solution in | |||
10 mL vials, packaged individually. | |||
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] | |||
Preservative Free. Discard unused portion. | |||
Duraclon® is a licensed registered trademark. | |||
Manufactured for: | |||
Mylan Institutional LLC | |||
Rockford, IL 61103 U.S.A. | |||
Manufactured by: | |||
Mylan Institutional | |||
Galway, Ireland | |||
0764L102 | |||
REVISED JUNE 2012 | |||
MI:DURAIJ:R2 | |||
To request medical information or to report suspected adverse reactions, contact Drug Safety at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638#i4i_clinical_pharmacology_id_a61d4026-7aae-4211-9bb5-332675db4e46 | publisher = | date = | accessdate = 6 February 2014 }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 17:41, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information, click here.
Indications and Usage
NDC 67457-218-10, 100 mcg/mL solution in 10 mL vials, packaged individually.
NDC 67457-219-10, 500 mcg/mL solution in 10 mL vials, packaged individually.
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Preservative Free. Discard unused portion.
Duraclon® is a licensed registered trademark.
Manufactured for: Mylan Institutional LLC Rockford, IL 61103 U.S.A.
Manufactured by: Mylan Institutional Galway, Ireland
0764L102 REVISED JUNE 2012 MI:DURAIJ:R2
To request medical information or to report suspected adverse reactions, contact Drug Safety at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch [1]
References
- ↑ "DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]". Retrieved 6 February 2014.